Brought to you by 
Galderma licenses PhotoCure's cancer treatment
30 Jan 2023
Executive Summary
Galderma SA (dermatology JV owned by L'Oreal and Nestlé) licensed exclusive worldwide marketing rights outside of Nordic countries to PhotoCure ASA's (photodynamic therapy) cancer treatment Metvix (methyl aminolevulinate).
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Alliance
- Includes Equity
- Includes Royalty or Profit Split Information
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Galderma licenses PhotoCure's cancer treatment
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice